Clinical Trial Update: Accupower ® HBV Performance Evaluation Quant Kit Bioneer Existation FA 96/384

View source ↗

Summary

CerbaXpert is conducting a clinical trial evaluating the Accupower HBV Performance Evaluation Quant Kit Bioneer Existation FA 96/384 for Hepatitis B. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Accupower HBV Performance Evaluation Quant Kit Bioneer Existation FA 96/384

Snippet

Sponsor: CerbaXpert | Conditions: Hepatitis B | Status: RECRUITING